Live News Categoriesmarket

AMLX.O (AMLX.O) News

Follow AMLX.O (AMLX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol AMLX.O Asset market Sector Markets 90 days 1 Updated Oct 06, 2026, 12:01 PM UTC Open live news feed

M Amylyx Pharma to present topline data from Phase 3 LUCIDITY trial of avexitide Amylyx Pharmaceuticals will present topline data from its Phase 3 LUCIDITY clinical trial of avexitide, an investigational treatment for post-bariatric hypoglycemia, at the ObesityWeek® 2026 Annual Meeting. The trial met EQUITY | Oct 06, 2026, 12:01 PM UTC